(19)
(11) EP 4 583 855 A1

(12)

(43) Date of publication:
16.07.2025 Bulletin 2025/29

(21) Application number: 23783649.9

(22) Date of filing: 07.09.2023
(51) International Patent Classification (IPC): 
A61K 31/122(2006.01)
A61K 31/355(2006.01)
A61K 31/52(2006.01)
A61K 38/00(2006.01)
A61K 41/00(2020.01)
A61P 35/00(2006.01)
A61K 31/352(2006.01)
A61K 31/4745(2006.01)
A61K 35/00(2006.01)
A61K 39/00(2006.01)
A61K 45/06(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 45/06; A61P 35/00; A61K 31/122; A61K 31/355; A61K 31/352; A61K 31/4745; A61K 31/52; A61K 38/00; A61N 2005/1098; A61K 38/20; A61K 38/2006; A61K 38/204; A61K 35/17; C07K 16/2896; C07K 2317/75; C07K 16/40; C07K 2317/76; A61K 2039/507
 
C-Sets:
  1. A61K 31/52, A61K 2300/00;
  2. A61K 38/20, A61K 2300/00;
  3. A61K 38/2006, A61K 2300/00;
  4. A61K 38/204, A61K 2300/00;
  5. A61K 35/17, A61K 2300/00;
  6. A61K 31/122, A61K 2300/00;
  7. A61K 31/355, A61K 2300/00;
  8. A61K 31/352, A61K 2300/00;
  9. A61K 31/4745, A61K 2300/00;

(86) International application number:
PCT/US2023/073674
(87) International publication number:
WO 2024/054934 (14.03.2024 Gazette 2024/11)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 07.09.2022 US 202263404392 P
17.03.2023 US 202363491008 P

(71) Applicant: MDX Management LLC
La Jolla, CA 92037 (US)

(72) Inventors:
  • LIU, Yuan
    Decatur, Georgia 30033 (US)
  • SHI, Lei
    Decatur, Georgia 30032 (US)
  • BIAN, Zhen
    Tucker, Georgia 30084 (US)
  • STYLLI, Harry
    La Jolla, California 92037 (US)

(74) Representative: CMS Cameron McKenna Nabarro Olswang LLP 
Cannon Place 78 Cannon Street
London EC4N 6AF
London EC4N 6AF (GB)

   


(54) SHP-1 INHIBITORS FOR TREATING CANCER